Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 330583Generated: October 29, 2026

Chloroform → Dotma dopc

https://huagongshe.com/reaction/330583

Reaction equation

Participants

RoleNameHCIDCharge
ReactantChloroformHCID 6212—
ReactantMaleimideHCID 10935—
Reactant1,2-Dioleoyl-sn-glycero-3-phospho(1-rac-glycerol)HCID 119120—
Reactant1,2-Dioleoyl-sn-glycero-3-phosphocholineHCID 10350317—
ProductDotma dopcHCID 131716290—

Reaction Steps

Maleimide-PE (chemical name: dioleoylphosphatidylethanolamine 4-(N-maleimidomethyl)-cyclohexane-1-carboxylate) was prepared by mixing 17 mg succinimidyl 4-(N-maleimidomethyl) clyclohexane-1-carboxylate (SMCC), with 7 μl triethylamine and 25 mg dioleoyl-phosphatidylethanolamine (DOPE) in 2.5 ml of chloroform. The mixture was sealed tightly to prevent evaporation and stirred at room temperature overnight. The reaction mixture was washed, 3×2 ml, with 5% methanol in water. The chloroform was then dried over anhydrous sodium sulfate and the sample was applied to the top of a silica gel column (1×5 cm). The column was eluted with chloroform (5 ml), 5% methanol in chloroform (5 ml), 10% methanol in chloroform (5 ml), and finally 20% methanol in chloroform until all of the product was eluted. The fractions containing product were pooled and solvent removed on a rotary evaporator to give the 28 mg of maleimide-PE as white, oily residue. The material was estimated to be greater then 95% pure by thin layer chromatography on silica gel chloroform-methanol-acetic acid (60:20:3) and was used without further purification. DOPG/DOPC sonicated vesicles containing maleimide-PE were prepared by dissolving 16 mg DOPG, 24 mg DOPC and 0.4 mg maleimide-PE in chloroform and removing the solvent by drying under a stream of nitrogen gas. This dried film was placed under vacuum overnight to remove traces of solvent. The film was then suspended in 0.8 ml water with vigorous shaking and sonicated in a bath type sonicator for 30 minutes until clear producing DOTMA/DOPC SUV's at a concentration of 50 mg/ml.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04897355
Source datasetuspto-grants-1990_01
ORD IDord-ac41a7140e8540cdbd685e9ec1372377
Source noteuspto-grants-1990_01